Ironwood Pharmaceuticals Inc SEC filings IRWD
Ironwood Pharmaceuticals Inc has 1,003 filings in SEC EDGAR's recent list, going back to Nov 4, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Mar 3, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Dec 6, 2023 | — |
| CORRESP | Letter to the SEC | Nov 30, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| SC TO-T/A | Filing | Jun 29, 2023 | — |
| SC TO-T/A | Filing | Jun 26, 2023 | — |
| SC TO-T/A | Filing | Jun 20, 2023 | — |
| SC TO-T/A | Filing | Jun 16, 2023 | — |
| SC TO-T | Filing | May 31, 2023 | — |
| SC TO-C | Filing | May 23, 2023 | — |
| SC TO-C | Filing | May 22, 2023 | — |
| SC TO-C | Filing | May 22, 2023 | — |
| CT ORDER | Filing | Apr 26, 2019 | — |
| CT ORDER | Filing | Apr 26, 2019 | — |
| CT ORDER | Filing | Mar 19, 2019 | — |
| 8-A12B/A | Filing | Jan 3, 2019 | — |
| PRRN14A | Preliminary proxy statement amendment | May 10, 2018 | — |
| UPLOAD | Letter from the SEC | May 9, 2018 | — |
| CORRESP | Letter to the SEC | May 2, 2018 | — |
| DEFC14A | Filing | May 2, 2018 | — |
| PREN14A | Preliminary proxy statement | May 1, 2018 | Apr 19, 2018 |
| UPLOAD | Letter from the SEC | Apr 26, 2018 | — |
| CORRESP | Letter to the SEC | Apr 16, 2018 | — |
| PREC14A | Filing | Apr 16, 2018 | — |
| CT ORDER | Filing | Dec 15, 2017 | — |
| CT ORDER | Filing | Jun 1, 2017 | — |
| D | Filing | Oct 11, 2016 | — |
| CT ORDER | Filing | Sep 20, 2016 | — |
| CT ORDER | Filing | Apr 6, 2016 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IRWD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1446847
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.